Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Eyenovia
(NASDAQ:EYEN)
Intraday
$0.64
-0.0713
[-10.02%]
After-Hours
$0.64
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.64
-0.0713
[-10.02%]
At close: Apr 26
$0.64
0
[0.00%]
After Hours: 7:55PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Eyenovia Stock (NASDAQ:EYEN)
Eyenovia Stock (NASDAQ: EYEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
2 days ago
Eyenovia shares are trading higher after the company announced clinical and scientific updates on its FDA-approved products Mydcombi and Clobetasol Propionate Ophthalmic Suspension.
Benzinga Newsdesk
-
2 days ago
Eyenovia Provides Clinical and Scientific Update On FDA-Approved Products Mydcombi And Clobetasol Propionate Ophthalmic Suspension
Benzinga Newsdesk
-
2 days ago
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Apr 10, 2024, 12:31PM
Monday, April 08, 2024
Eyenovia Initiates Process To Explore Strategic Alternatives To Maximize Shareholder Value
Benzinga Newsdesk
-
Apr 8, 2024, 7:02AM
Thursday, March 21, 2024
Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor
-
Mar 21, 2024, 6:45AM
Tuesday, March 19, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Mar 19, 2024, 1:31PM
Eyenovia shares are trading lower after the company reported worse-than-expected Q4 financial results.
Benzinga Newsdesk
-
Mar 19, 2024, 11:52AM
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Benzinga Newsdesk
-
Mar 19, 2024, 7:00AM
Monday, March 18, 2024
Recap: Eyenovia Q4 Earnings
Benzinga Insights
-
Mar 18, 2024, 4:30PM
Eyenovia Q4 EPS $(0.18) Misses $(0.17) Estimate, Sales $2.59K Miss $130.00K Estimate
Benzinga Newsdesk
-
Mar 18, 2024, 4:26PM
Earnings Scheduled For March 18, 2024
Benzinga Insights
-
Mar 18, 2024, 5:57AM
Friday, March 15, 2024
Earnings Preview For Eyenovia
Benzinga Insights
-
Mar 15, 2024, 11:01AM
Wednesday, March 13, 2024
NovaBay Pharmaceuticals And Eyenovia To Co-Promote Prescription Ophthalmic Products To U.S. Eyecare Professionals
Benzinga Newsdesk
-
Mar 13, 2024, 7:08AM
Wednesday, March 06, 2024
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Benzinga Newsdesk
-
Mar 6, 2024, 8:12AM
Tuesday, March 05, 2024
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 5, 2024, 1:11PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Mar 5, 2024, 12:33PM
Beyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammation
Vandana Singh
-
Mar 5, 2024, 10:59AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Mar 5, 2024, 8:09AM
Monday, March 04, 2024
Formosa And AimMax Therapeutics Secure FDA Approval For Clobetasol Propionate Ophthalmic Suspension 0.05%, For Treatment Of Post-Operative Inflammation And Pain Following Ocular Surgery
Benzinga Newsdesk
-
Mar 4, 2024, 5:59PM
Tuesday, January 16, 2024
Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the US and Canada, To Pay Bausch + Lomb Ireland Limited an Upfront Payment Consisting of $2M in Cash and $3M in Shares
Benzinga Newsdesk
-
Jan 16, 2024, 7:05AM
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 15, 2024, 4:30PM
Wednesday, December 06, 2023
Insiders Buying Eyenovia And 3 Other Stocks Under $2
Lisa Levin
-
Dec 6, 2023, 7:16AM
Tuesday, November 14, 2023
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Benzinga Newsdesk
-
Nov 14, 2023, 6:41AM
Monday, November 13, 2023
Eyenovia Q3 EPS $(0.18), Inline, Sales $1.20M Beat $150.00K Estimate
Benzinga Newsdesk
-
Nov 13, 2023, 5:17PM
Earnings Scheduled For November 13, 2023
Benzinga Insights
-
Nov 13, 2023, 6:40AM
Friday, November 10, 2023
Earnings Preview: Eyenovia
Benzinga Insights
-
Nov 10, 2023, 12:02PM
Wednesday, November 01, 2023
Eyenovia's Stock Is Soaring Today - Here's Why
Vandana Singh
-
Nov 1, 2023, 3:05PM
Eyenovia shares are trading higher after William Blair initiated coverage on the stock with an Outperform rating.
Benzinga Newsdesk
-
Nov 1, 2023, 1:24PM
William Blair Initiates Coverage On Eyenovia with Outperform Rating
Benzinga Newsdesk
-
Nov 1, 2023, 11:02AM
Monday, October 30, 2023
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 30, 2023, 8:44AM
Tuesday, October 17, 2023
Brookline Capital Initiates Coverage On Eyenovia with Buy Rating, Announces Price Target of $8
Benzinga Newsdesk
-
Oct 17, 2023, 11:34AM
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 10, 2023, 1:09PM
Wednesday, September 20, 2023
Porch Group And 2 Other Stocks Under $3 Insiders Are Buying
Lisa Levin
-
Sep 20, 2023, 7:58AM
Thursday, August 24, 2023
Eyenovia Announces $12M Registered Direct Offering
Happy Mohamed
-
Aug 24, 2023, 6:59PM
Friday, August 18, 2023
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Benzinga Newsdesk
-
Aug 18, 2023, 6:14AM
Wednesday, August 16, 2023
Eyenovia Acquires U.S. Commercial Rights To Commercialize APP13007 To Treat Post Ocular Surgery Pain And Inflammation
Benzinga Newsdesk
-
Aug 16, 2023, 6:02AM
Friday, August 11, 2023
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Benzinga Newsdesk
-
Aug 11, 2023, 7:46AM
Thursday, August 10, 2023
Eyenovia Q2 EPS $(0.16) Beats $(0.17) Estimate
Benzinga Newsdesk
-
Aug 10, 2023, 4:16PM
Earnings Scheduled For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 6:59AM
Wednesday, August 09, 2023
Earnings Preview For Eyenovia
Benzinga Insights
-
Aug 9, 2023, 2:01PM
Thursday, August 03, 2023
Eyenovia Announces First Commercial Sale Of Mydcombi
Happy Mohamed
-
Aug 3, 2023, 8:23AM
Monday, June 26, 2023
Eyenovia Announces Addition To Russell 2000 And Russell 3000 Indexes
Benzinga Newsdesk
-
Jun 26, 2023, 8:15AM
Friday, May 12, 2023
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
Benzinga Newsdesk
-
May 12, 2023, 8:59AM
Thursday, May 11, 2023
Recap: Eyenovia Q1 Earnings
Benzinga Insights
-
May 11, 2023, 4:35PM
Eyenovia Q1 EPS $(0.15) Beats $(0.19) Estimate
Benzinga Newsdesk
-
May 11, 2023, 4:33PM
Earnings Scheduled For May 11, 2023
Benzinga Insights
-
May 11, 2023, 9:58AM
Wednesday, May 10, 2023
A Preview Of Eyenovia's Earnings
Benzinga Insights
-
May 10, 2023, 12:01PM
Monday, May 08, 2023
Eyenovia Shares Dip Despite FDA Approving Its First Product
Vandana Singh
-
May 8, 2023, 2:39PM
Eyenovia Announces FDA Approval Of Mydcombi Ophthalmic Spray For Mydriasis
Benzinga Newsdesk
-
May 8, 2023, 8:04AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch